Inactivating protein synthesis by incubating anti-Thy 1.1-ricin

Drug – bio-affecting and body treating compositions – Lymphokine

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 8, A61K 3944, A61K 39395, A61K 4505

Patent

active

045200114

ABSTRACT:
The rate of protein synthesis inhibition is significantly increased by adding excess ricin B chain to target cells independent of the amount of ricin A chain bound to the cell surface membrane. Ricin is a known toxin from albumin of the castor oil bean and contains an A chain and a B chain for binding to receptors. The present invention is concerned with ricin hybrids such as OX-7-ricin A chain and 19E12-F(ab) ricin A chain which were produced by conjugation of the ricin A chains with anti-Thy 1.1 monoclonal antibodies. The conjugates were utilized in pharmaceutical amounts in mice.

REFERENCES:
patent: 4356117 (1982-10-01), Neville et al.
patent: 4359457 (1982-11-01), Neville, Jr. et al.
patent: 4397843 (1983-08-01), Neville et al.
Youle et al., Proc. Natl. Acad. Sci., U.S.A., vol. 77, No. 9, pp. 5483-5486 (1980).
Masuho et al., Biochem. Biophys. Res. Comm., 90: 320-326 (1979).
Neville/Youle, Immunology Reviews, vol. 62, p. 135, 1981.
Vallera et al., "Bone Marrow Transplantation Across Major Histocompatibility Barriers".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Inactivating protein synthesis by incubating anti-Thy 1.1-ricin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inactivating protein synthesis by incubating anti-Thy 1.1-ricin , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inactivating protein synthesis by incubating anti-Thy 1.1-ricin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-868377

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.